
Philipp Schommers
Articles
-
Oct 13, 2024 |
nature.com | Henning Gruell |Philipp Schommers
In a recent article in Science, Leon Weinberger and colleagues report on successful proof-of-concept studies of a novel strategy to control HIV-1 infection by using interfering viral particles.1 This approach radically differs from small-molecule antiretroviral drugs that can prevent disease progression and transmission by inhibiting viral replication but require life-long use.
-
Jul 19, 2024 |
thelancet.com | Clara Lehmann |Philipp Schommers
With approximately 1·3 million new HIV type 1 (HIV-1) infections still occurring annually, there is an urgent need for an effective vaccine against HIV-1 acquisition. 1UNAIDSFact sheet 2023. Joint United Nations rogramme on HIV/AIDS. Since the first vaccine trials in the late 1980s, a variety of vaccine strategies have been tested over the past four decades. 2Haynes BF Wiehe K Borrrow P et al. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.
-
Nov 12, 2023 |
nature.com | Philipp Schommers |Dae Sung Kim |Christoph Kreer |Henning Gruell |Elena Knops |Timo Wolf | +10 more
AbstractHuman immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from HIV-1 neutralizers—persons with HIV-1 who naturally develop broad and potent nAbs—can inform about the dynamics and durability of nAb responses in humans, knowledge which is crucial for the design of future HIV-1 vaccine regimens.
-
Oct 4, 2023 |
thelancet.com | Philipp Schommers
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →